Study Group: Council Members in Member Programs who Treat Fusarium Keratitis
Council Members in this Study Group: 51
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Sanjay RaoMedical Director
Lakeside Eye Clinic
Sanjay Rao, MD, is the Medical Director and Director of Cornea and Refractive Surgery at the Lakeside Eye Clinic in Chicago. He was previously the Director of Cornea and Refractive Surgery at the University of Chicago. He has clinical expertise in diseases...
Gaurav ShahAssociate Professor of Ophthalmology
WASHINGTON UNIVERSITY MEDICAL CENTERGaurav Shah, MD, is an Associate Professor of Ophthalmology at the Washington University Medical Center in Missouri. He is a national expert in the care of patients with diabetic retinopathy/diabetic macular edema, age-related macular degeneration, retinal...
Barry SchechterDirector of Corneal and External Diseases
FLORIDA EYE MICROSURGICAL INSTITUTE INCBarry Schechter, MD, is the Director of Department of Cornea and External Disease at Florida Eye Microsurgical Institute. Dr. Schechter's practice involves diseases of the ocular surface including dry eyes, allergies, infection; the latest in corneal,...
- Andrew Dahl
President
Ophthalmology ConsultantsAndrew Dahl, MD, FACS, FAAO, is the President of Ophthalmology Consultants in New York. He was also Principal Investigator for Hudson Valley Eye Research Foundation and has conducted numerous clinical trials. Dr. Dahl is a board-certified Ophthalmologist/Ophthalmic...
- Hal Breedlove
Owner and Clinical Director
Coastal VisionHal Breedlove, OD, is the Owner and Clinical Director of Coastal Vision, a five Optometrist practice in Virginia Beach, Chesapeake, and Norfolk Virginia. In practice for over 26 years, he has expertise in a many areas of vision research, patient care,...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Lumigan X EU Committee Recomendation
October 27, 2009
Analysis by: Andrew Dahl, President ,EU committee backs marketing approval of Lumigan | www.pharmabiz.com
The Committee for Medicinal Products for Human Use (CHMP) of the European Union has recommended granting a Marketing Authorization for a new version of Allergan's Lumigan (bimatoprost ophthalmic solution). This new version will be marketed as Lumigan-X after approval. Lumigan X offers Allergan a new formulation to compete against generic versions of its glaucoma drug Lumigan after patent protection for Lumigan expires shortly.There will be very limited demand for Lumigan-X.
-
Contact Lens Nirvana: Hyperpermeable One Day
October 2, 2009
Analysis by: Steve Rubinstein, Optometrist,Hobby assists Irish strategy | www.opticianonline.net
This article describes resources being put into place to mass produce the first commercially available silicon hydrogel one day disposable contact lens in the USA by Johnson & Johnson's Vistakon division.
-
Alcon, Novartis (Ciba Vision), Astra-Zeneca working on ocular medications?
July 23, 2009
Analysis by: Steve Rubinstein, Optometrist,Alcon Signs Agreement With AstraZeneca On Eye Drug Development | www.pharmaceutical-business-review.com
This agreement seems to allow Alcon Laboratories, Inc and Astra-Zeneca to work together to produce ocular medications. What it doesn't say is that they can also use Ciba Vision's resources in the near future.
-
A drop in the price of OTC allergy eye drops?
July 5, 2009
Analysis by: Steve Rubinstein, Optometrist,Sun Pharmaceutical gets tentative nod from USFDA for ‘Optivar Solution’ | Top News | www.topnews.in
By adding a third OTC antihistamine eye drop to the mix the price competition should make the cost to the consumer decrease.
-
Laser Vision Correction for Presbyopia is here!
April 6, 2009
Analysis by: Steve Rubinstein, Optometrist,Presbyopic laser vision correction reduces spectacle dependence in pseudophakes | www.modernmedicine.com
The missing element in LVC today is real multifocal correction to deal with a the large population of baby boomers that are finding a need for a different correction for distance vision than near vision(most people over 40 years of age). As of now we have only two options for adults: 1) two eyes corrected for distance vision and reading glasses or 2) mono-vision, one eye corrected for near, and the other corrected for distance vision. We currently have the ability to create mulitfocal spectacle lenses, and multifocal contact lenses. Johnson & Johnson's Vistakon just released a new Acuvue for Presbyopia in March 2009, CooperVision and Bausch & Lomb have both had multifocal contact lenses for years.
Members in this Study Group include these company types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Free-standing Surgery Center
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Owner
- President
- Partner
- Optometrist
- Physician - Division Head
- Allied Health Professional
- Physician - Department Chair
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
November 20, 2006 | San Francisco
GLGi: Intraocular Lenses (IOLs)May 9, 2006 | Chicago
GLGi: OphthalmologyApril 19, 2006 | New York
GLGi: Ophthalmology Grand RoundsGLG Webcasts & Teleconferences
Leading Experts in Council Members in Member Programs who Treat Fusarium Keratitis have not participated in any GLG webcasts.